Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for Non-Small Cell Lung Cancer
Hyun-Seock Shin, Juwhan Choi, Jinhwan Lee, Sung Yong Lee
Cancer Res Treat. 2022;54(2):458-468. Published online 2021 Sep 10 DOI: https://doi.org/10.4143/crt.2021.425
Citations to this article as recorded by 
Epigenetic Modification of PD-1/PD-L1-Mediated Cancer Immunotherapy against Melanoma
Hikaru Nanamori, Yu Sawada
International Journal of Molecular Sciences.2022; 23(3): 1119. CrossRef
Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer
Shuo Yang, Yang Huang, Qi Zhao
Frontiers in Immunology.2022;[Epub] CrossRef